GE HealthCare Technologies (STU:L0T) ROCE %: 8.59% (As of Mar. 2026)


STU:L0T GE HealthCare Technologies Inc STU:L0T
72 GF Score
Price €57.67
GF Value €74.58
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is GE HealthCare Technologies ROCE %?

GE HealthCare Technologies STU:L0T +1.37% 72 ROCE % is 8.59% as of Mar. 2026. GuruFocus rates STU:L0T with a GF Score™ of 72/100 and a GF Value™ of €74.58 (Modestly Undervalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. GE HealthCare Technologies's annualized ROCE % for the quarter that ended in Mar. 2026 was 8.59%.

GE HealthCare Technologies  (STU:L0T) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

GE HealthCare Technologies ROCE % Related Terms

GE HealthCare Technologies ROCE % Historical Data

* Premium members only.

The historical data trend for GE HealthCare Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GE HealthCare Technologies ROCE % Chart

GE HealthCare Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 16.20 13.44 13.07 13.40 11.86

GE HealthCare Technologies Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.41 11.40 11.54 13.77 8.59
STU:L0T
72GF Score
GE HealthCare Technologies Inc STU:L0T
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GE HealthCare Technologies ROCE % Calculation

GE HealthCare Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=2739.632/( ( (31599.995 - 9123.115) + (31517.724 - 7775.67) )/ 2 )
=2739.632/( (22476.88+23742.054)/ 2 )
=2739.632/23109.467
=11.86 %

GE HealthCare Technologies's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=2082.92/( ( (31517.724 - 7775.67) + (32113.125 - 7377.585) )/ 2 )
=2082.92/( ( 23742.054 + 24735.54 )/ 2 )
=2082.92/24238.797
=8.59 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 8.59% mean?
GE HealthCare Technologies (STU:L0T) has a ROCE % of 8.59% as of Mar. 2026.
Is GE HealthCare Technologies' ROCE % too high?
GE HealthCare Technologies' current ROCE % is 8.59%. The Medical Devices & Instruments industry median ROCE % is 2.20. GE HealthCare Technologies' value of 8.59% is 290.5% above this industry median. Overall, GE HealthCare Technologies has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' ROCE % compare to DXCM and STE?
GE HealthCare Technologies' ROCE % of 8.59% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. GE HealthCare Technologies' value of 8.59% is 290.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GE HealthCare Technologies's current ROCE % of 8.59% is 290.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GE HealthCare Technologies's current ROCE % is 8.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (STU:L0T) is currently considered Modestly Undervalued. The stock's GF Value™ is €74.58, compared to a current price of €57.67 — trading 22.7% below its estimated fair value. The current ROCE % is 8.59% and 290.5% above the Medical Devices & Instruments industry median of 2.20. GE HealthCare Technologies' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For GE HealthCare Technologies (STU:L0T), the current ROCE % is 8.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GE HealthCare Technologies (STU:L0T) Overvalued in 2026?

Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued. The current stock price of €57.67 is trading 22.7% below its estimated GF Value™ of €74.58. GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.

Key valuation signals for STU:L0T:

  • ROCE %: 8.59%
  • GF Value™: €74.58 vs. price of €57.67 (22.7% below fair value)
  • GF Score™: 72/100 with 4 warning signs
  • Industry Position: 290.5% above the Medical Devices & Instruments median

No single metric tells the full story. See the STU:L0T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GE HealthCare Technologies Business Description

Address 500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
72GF Score

Get the complete analysis for STU:L0T

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€57.67
Price
€74.58
GF Value